Raymond James Financial’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
Raymond James Financial's DXCM Position: Q3 2026 in Review
Raymond James Financial increased its DexCom (DXCM) stake by 2.4% in Q3 2026, buying an estimated $6.05M and bringing the position to 3,160,652 shares worth $273M. The position accounts for 0.07% of the portfolio, ranked #237.
Raymond James Financial first reported a position in DXCM in Q4 2024 and has held it in 8 quarters since. The position peaked at $295M in Q2 2025. 1,049 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.
- Raymond James Financial held 3,160,652 shares of DexCom worth $273M as of Q3 2026.
- Raymond James Financial bought 72,662 DexCom shares in Q3 2026, an estimated $6.05M.
- DexCom made up 0.07% of Raymond James Financial's portfolio in Q3 2026, its #237 holding.
- Raymond James Financial first reported a position in DexCom in Q4 2024 and has held it in 8 quarters since.
- Raymond James Financial's DexCom position peaked at $295M in Q2 2025.
- 1,049 funds tracked by Wall St. Rank held DexCom as of Q3 2026.
Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.